0001225208-13-014061.txt : 20130606
0001225208-13-014061.hdr.sgml : 20130606
20130606163113
ACCESSION NUMBER: 0001225208-13-014061
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130605
FILED AS OF DATE: 20130606
DATE AS OF CHANGE: 20130606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elicker John E
CENTRAL INDEX KEY: 0001554788
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 13897677
MAIL ADDRESS:
STREET 1: BRISTOL-MYERS SQUIBB COMPANY
STREET 2: ROUTE 206 & PROVINCELINE ROAD
CITY: LAWRENCEVILLE
STATE: NJ
ZIP: 08543
4
1
doc4.xml
X0306
4
2013-06-05
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001554788
Elicker John E
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
1
SVP Pub Affairs & Inv Relation
Common Stock, $0.10 par value
2013-06-05
4
M
0
19723.0000
17.5100
A
54278.9700
D
Common Stock, $0.10 par value
2013-06-05
4
M
0
7377.0000
22.1400
A
61655.9700
D
Common Stock, $0.10 par value
2013-06-05
4
M
0
6615.0000
27.0100
A
68270.9700
D
Common Stock, $0.10 par value
2013-06-05
4
S
0
25997.0000
46.3300
D
42273.9700
D
Option (right to buy)
17.5100
2013-06-05
4
M
0
19723.0000
0.0000
D
2019-03-02
Common Stock, $0.10 par value
19723.0000
0.0000
D
Option (right to buy)
22.1400
2013-06-05
4
M
0
7377.0000
0.0000
D
2018-03-03
Common Stock, $0.10 par value
7377.0000
0.0000
D
Option (right to buy)
27.0100
2013-06-05
4
M
0
6615.0000
0.0000
D
2017-03-05
Common Stock, $0.10 par value
6615.0000
0.0000
D
The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $46.28 to $46.43, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 3, 2009.
Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 4, 2008.
Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 6, 2007.
/s/ Robert J. Wollin, attorney-in-fact for John E. Elicker
2013-06-06